Loading organizations...

§ Private Profile · 1200 Stewart Place, Springdale, AR 72764
NOWDiagnostics | NOWDx is a company.
NOWDiagnostics | NOWDx has raised $22.5M across 1 funding round.
Key people at NOWDiagnostics | NOWDx.
NOWDiagnostics | NOWDx has raised $22.5M in total across 1 funding round.
NOWDiagnostics develops and manufactures over-the-counter (OTC) and point-of-care (POC) diagnostic tests. Its patented "Touch to Test" technology enables accurate, one-step immunological assays from a small capillary blood sample, delivering rapid results. The First To Know® and ADEXUSDx® product lines emphasize accessible diagnostics for diverse health conditions.
Founded in 2013 by Jeremy Wilson, NOWDiagnostics originated from a direct request by a large retailer in northwest Arkansas for accessible, over-the-counter diagnostic tests. This insight spurred the development of rapid, in-home solutions. Based in Springdale, Arkansas, the company focused on meeting demand for convenient, efficient diagnostic capabilities.
NOWDiagnostics' products serve individuals seeking at-home testing and healthcare professionals utilizing point-of-care diagnostics. The company envisions universally accessible, affordable, and accurate testing. It transforms healthcare by empowering individuals with immediate health insights, expanding its range to include infectious diseases and women's health applications.
NOWDiagnostics | NOWDx has raised $22.5M across 1 funding round. Most recently, it raised $22.5M NOWDiagnostics - Series B in July 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 9, 2024 | $22.5M Series B | — | — | Announced |
Key people at NOWDiagnostics | NOWDx.
NOWDiagnostics (NOWDx) is a private diagnostics company that develops rapid, at‑home and point‑of‑care immunoassay tests that deliver results in minutes using small volumes of capillary blood, saliva or plasma; it is pursuing FDA clearance for an over‑the‑counter syphilis test and has a broad pipeline of over 30–31 products and 75+ patents supporting its platform[1][2].[1]
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech / Health Landscape
Quick Take & Future Outlook
If you’d like, I can: produce a one‑page investor brief with timelines and milestone risks, map NOWDx’s patent portfolio by priority date, or compare NOWDx to 3 peer companies in OTC/POC diagnostics.
NOWDiagnostics | NOWDx has raised $22.5M in total across 1 funding round.